Lifeboat Foundation

Tesla is planning to build its new design center in Beijing later this year, according to a new document released by the Chinese government.

Shortly after announcing Gigafactory Shanghai, Tesla made it clear that it not only wants to tap into China’s incredible capacity in manufacturing, but it also wants to take advantage of the country’s incredible engineering and design talent.

In early 2020, Tesla announced plans to establish a new R&D center and a new design center in China to build “a Chinese-style” electric car.

IBM has just announced a partnership with the Government of Quebec to create the Quebec-IBM Discovery Accelerator in Bromont, Quebec. The accelerator will focus on using quantum computing, Artificial Intelligence (AI), and High-Performance Computing (HPC) to develop new projects, business/scientific/academia collaborations, and skills-building initiatives in research areas including energy, life sciences (genomics and drug discovery), new materials development, and sustainability. This is the fourth such center that IBM has announced. The three previously announced partnerships are with Cleveland Clinic, the University of Illinois Urbana-Champaign, and the UK’s Science and Technology Facilities Council Hartree Centre. IBM’s formal mission statement for these Discovery Accelerators is: “Accelerate scientific discovery and societal impact with a convergence of AI, quantum, and hybrid cloud in a community of discovery with research, academic, industry, startup, and government organizations working together.” IBM’s formal mission statement for these Discovery Accelerators is:

“Accelerate scientific discovery and societal impact with a convergence of AI, quantum, and hybrid cloud in a community of discovery with research, academic, industry, startup, and government organizations working together.”

In addition, the company has developed individual mission statements for each of the four Discovery Accelerators:

The endless parade of bad news for Israeli malware merchant NSO Group continues. While it appears someone might be willing to bail out the beleaguered company, it still has to do business as the poster boy for the furtherance of human rights violations around the world. That the Israeli government may have played a significant part in NSO’s sales to known human rights violators may ultimately be mitigating, but for now, NSO is stuck playing defense with each passing news cycle.

Late last month, the New York Times revealed some very interesting things about NSO Group. First, it revealed the company was able to undo its built-in ban on searching US phone numbers… provided it was asked to by a US government agency. The FBI took NSO’s powerful Pegasus malware for a spin in 2019, but under an assumed name: Phantom. With the permission of NSO and the Israeli government, the malware was able to target US numbers, albeit ones linked to dummy phones purchased by the FBI.

The report noted the FBI liked what it saw, but found the zero-click exploit provided by NSO’s bespoke “Phantom” (Pegasus, but able to target US numbers) might pose constitutional problems the agency couldn’t surmount. So, it walked away from NSO. But not before running some attack attempts through US servers — something that was inadvertently exposed by Facebook and WhatsApp in their lawsuit against NSO over the targeting of WhatsApp users. An exhibit declared NSO was using US servers to deliver malware, something that suggested NSO didn’t care about its self-imposed restrictions on US targeting. In reality, it was the FBI and NSO running some tests on local applications of zero-click malware that happened to be caught by Facebook techies.

😃

CHICAGO, Feb 4 (Reuters) — A study in monkeys pitting the current Moderna Inc (MRNA.O) COVID-19 booster against an Omicron-specific booster showed no significant differences in protection, suggesting an Omicron-specific booster may not be needed, U.S. government researchers reported on Friday.

The study involved monkeys vaccinated with two doses of Moderna’s vaccine who were dosed nine months later with either the conventional Moderna booster or one specifically targeting the Omicron variant.

Continue reading “Omicron-specific booster may not be needed, U.S. monkey study finds” »

New South Wales has again received an overwhelming response from aspiring developers of wind, solar and storage projects, with more than 34GW of proposals for the South-West Renewable Energy Zone, more than 10 times its likely capacity.

The state government, through its newly formed Energy Corporation of NSW, ran a registration of interest process in October and November for the south-west region, one of at least five REZs planned to help replace the ageing coal fleet over the coming decade.

“There were 49 registrations totalling over 34 gigawatts from potential generation and storage projects – thirteen times the intended capacity for the South-West REZ, which will be no less than 2.5 gigawatts,” James Hay, the CEO of Energy Corp, said in a statement on Friday.

Neuralink, the startup cofounded and run by Elon Musk that hopes to implant computer chips in people’s brains, may have misled federal securities regulators about the billionaire entrepreneur’s role at the company.

That’s according to government documents and Fortune interviews with securities lawyers and a half-dozen former employees of the company. The employees mostly spoke anonymously out of concern for violating nondisclosure agreements and possible retaliation from Musk.

The episode involves a 2018 letter in which an attorney representing Neuralink downplayed Musk’s leadership role at the company in a letter to the Securities and Exchange Commission. The attorney’s characterization contradicts former employees’ accounts, which depict Musk as very much in charge. Neuralink and the attorney involved in the filing did not respond to requests for comment. lawyer for Neuralink told the SEC that Musk had “no executive or management role” at the company. Former employees say that’s far from the truth.

Quantum computing is still rare enough that merely installing a system in a country is a breakthrough, and IBM is taking advantage of that novelty. The company has forged a partnership with the Canadian province of Quebec to install what it says is Canada’s first universal quantum computer. The five-year deal will see IBM install a Quantum System One as part of a Quebec-IBM Discovery Accelerator project tackling scientific and commercial challenges.

The team-up will see IBM and the Quebec government foster microelectronics work, including progress in chip packaging thanks to an existing IBM facility in the province. The two also plan to show how quantum and classical computers can work together to address scientific challenges, and expect quantum-powered AI to help discover new medicines and materials.

IBM didn’t say exactly when it would install the quantum computer. However, it will be just the fifth Quantum One installation planned by 2023 following similar partnerships in Germany, Japan, South Korea and the US. Canada is joining a relatively exclusive club, then.

Phase I trial aims to build on response seen in proof-of-concept trial.

NEW YORK AND CAMBRIDGE, MASS. — JANUARY 27, 2022 — IAVI and biotechnology company Moderna announced today that first doses have been administered in a clinical trial of experimental HIV vaccine antigens at George Washington University (GWU) School of Medicine and Health Sciences in Washington, D.C. The Phase I trial, IAVI G002, is designed to test the hypothesis that sequential administration of priming and boosting HIV immunogens delivered by messenger RNA (mRNA) can induce specific classes of B-cell responses and guide their early maturation toward broadly neutralizing antibody (bnAb) development. The induction of bnAbs is widely considered to be a goal of HIV vaccination, and this is the first step in that process. The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna’s mRNA technology.

IAVI and Moderna and do not necessarily reflect the views of USAID or the United States government.

Continue reading “IAVI and Moderna launch trial of HIV vaccine antigens delivered through mRNA technology” »